Phytosterols: Nutritional Health Players in the Management of Obesity and Its Related Disorders.
Teresa VezzaFrancisco CanetAránzazu Martínez de MarañonCelia BañulsMilagros RochaVíctor Manuel VíctorPublished in: Antioxidants (Basel, Switzerland) (2020)
Obesity and its related disorders, such as diabetes and cardiovascular risk, represent an emerging global health issue. Even though genetic factors seem to be the primary actors in the development and progression of these diseases, dietary choices also appear to be of crucial importance. A healthy diet combined with physical activity have been shown to ameliorate glycaemic levels and insulin sensitivity, reduce body weight and the risk of chronic diseases, and contribute to an overall improvement in quality of life. Among nutrients, phytosterols have become the focus of growing attention as novel functional foods in the management of metabolic disorders. Phytosterols are natural plant compounds belonging to the triterpene family and are structurally similar to cholesterol. They are known for their cholesterol-lowering effects, anti-inflammatory and antioxidant properties, and the benefits they offer to the immune system. The present review aims to provide an overview of these bioactive compounds and their therapeutic potential in the fields of obesity and metabolic disorders, with special attention given to oxidative stress, inflammatory status, and gut dysbiosis, all common features of the aforementioned diseases.
Keyphrases
- type diabetes
- weight loss
- oxidative stress
- insulin resistance
- body weight
- physical activity
- metabolic syndrome
- global health
- anti inflammatory
- high fat diet induced
- weight gain
- public health
- working memory
- healthcare
- body mass index
- cardiovascular disease
- glycemic control
- mental health
- genome wide
- low density lipoprotein
- ischemia reperfusion injury
- social media
- skeletal muscle
- depressive symptoms
- dna damage
- adipose tissue
- copy number
- diabetic rats
- induced apoptosis